Top Indices & Stocks

Trading
Stocks
Suven Life Sciences Ltd Share Price

Suven Life Sciences Share Price

SUVEN EQ

BSE NSE

₹ 61.45

+0.55 (+0.90%)

100% Buy 👍

BUY SELL

Suven Life Sciences Ltd Quick Overview

Suven Life Sciences Limited provides a wide range of drug discovery and development support services to global pharma and biotech companies. It has state-of-art facilities with a highly qualified & experienced team of scientists. It offers research services specializing in synthetic, medicinal and analytical chemistry, in-vitro assay development and screening, drug metabolism & pharmacokinetics, CNS pharmacology (behavioral pharmacology, microdialysis, receptor occupancy, electrophysiology), toxicology and safety pharmacology, bioanalysis, and NCE formulations. Its discovery research is focused on discovering and developing new chemical entities (NCEs), which are best-in-class central nervous system therapies for the treatment of a diverse range of disorders such as cognitive disorders, major depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, and gastrointestinal motility disorders.

Pharmaceuticals

Market Cap

1,328.07 Crore
Open

₹61.35
Close

₹60.90
Circuit Range

₹49- ₹73.05
Day Range

₹60.80- ₹61.75
Year Range

₹59.50- ₹101.95
Volume

48,260.00
Avg. Traded

₹61.27

Investment Checklist

Equity Returns
Dividend returns
Safety Factor
Growth Factor
Debt vs Equity
Profit Factor

Suven Life Sciences Ltd Key Indicators

P/E Ratio

--
P/B Ratio

1.54
ROE

-8.62 %
ROCE

-8.10 %
Dividend Yield

--
Debt to equity

--

Financial Ratios

Profitability

Operational

Valuation

Op profit margin

-263.52 %
Net profit margin

-306.04 %
ROCE

-8.10 %
ROA

-6.65 %
ROE

-8.62 %

Quick Ratio

1.57
Current Ratio

1.57
Interest Coverage

-55.35
Asset Turnover

0.02
Debt to equity

--

P/E

--
P/B

1.54
EV / EBITDA

-43.12 %
Dividend Yield

--

Corporate Actions

Rights Issue ₹ 0

17 Oct 2022

Past

Announcement date	24 Jun 2022
Ex rights date	17 Oct 2022
Record date	18 Oct 2022
Ratio	1:2
Premium	54.00
Details	Rights Issue inter alia,approved: 1.Approved the raising of funds, through issuance and allotment of equity shares having face value of Rs. 1 each up to an aggregate amount of Rs. 400 Crores (Rupees Four Hundred Crores) on rights basis and on such terms (as decided by the Board or a duly constituted committee of the Board, at a later date) to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently), subject to receipt of regulatory/ statutory approvals, in accordance with the applicable laws including the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI LODR Regulations and the Companies Act, 2013, and rules and regulations made thereunder, each as amended from time to time and approved other related matters including the constitution of a Rights Issue Committee to implement the proposal of Rights Issue. 2.The Board of Directors has considered and approved increase in the Authorized Share Capital from Rs. 20 crores divided into 20 crores equity shares of Rs. 1/- each to Rs. 30 crores divided into 30 crores equity shares of Rs. 1/- each and consequential alteration in the Memorandum of Association of the Company, subject to the approval of shareholders of the Company.

Suven Life Sciences Ltd Shareholder returns

1 day

-1.77%
1 week

-6.88%
1 month

-11.03%
3 months

-1.3%
1 year

-31.61%
3 years

+ 173.71%
5 years

-72.87%

Suven Life Sciences Ltd Share Price History

Day	Open	Close	Day's change
Mon, Jan 30	61.00	60.90	-0.16%
Fri, Jan 27	64.45	62.00	-3.95%
Wed, Jan 25	63.15	64.45	2.02%
Tue, Jan 24	64.70	63.20	-2.37%
Mon, Jan 23	65.95	64.15	-2.81%
Fri, Jan 20	66.00	65.40	-0.92%
Thu, Jan 19	62.70	66.10	5.14%